Skip to main content
. 2019 Nov 13;25:e00397. doi: 10.1016/j.btre.2019.e00397

Table 1.

Some genes and pathways engineered to improve optical pure 2,3-BDO production.

Organism 2,3-BDO biosynthesis genes Pathway Precursor Isomer Titer (g/L) Enantiopurity Reference
Escherichia Coli K. pneumoniae budA, budB, budC Glucose meso- 17.7 98% [107]
K. pneumoniae budA, budC Conversion of R-acetoin to meso-butanediol Glucose meso- 15.3 99% [108]
K. pneumoniae budA, budC, ydjL from Bacillus subtilis No isopropyl beta-D-thiogalactoside (IPTG) addition Glucose (R,R) 115 99% [109]
Enterobacter cloacae knock out of bdh, ldh, and frdA, and inactivation of ptsG, and overexpression of (2R,3R) bdh and galP Blocking pathways of conversion from glucose to meso -2,3-BD, and pyrivate to lactate, succinate, and (2S, 3S)-2,3-BD Xylose and glucose (R,R) 152 98% [101]
Pichia pastoris B. subtilis alsS, alsD genes, and S.cerevisiaeBDH1 Conversion of pyruvate to R-acetoin, then converted to (2R, 3R)-2,3-butanediol Glucose (R,R) 74.5 99% [55]
Bacillus subtilis K. pneumoniae budC,
deletion of bdhA, pta and ldh,and knock out of acoA
Conversion of D-(-) acetoin to meso-2,3-BD Glucose meso- 103.7 99% [110]
Bacillus licheniformis Deletion of gldA Miscanthus floridulus
Hydrolysate
meso- 48.5 Not tested [111]